Journal of Clinical Oncology

Vol. 43, Issue 16_suppl Issue 16_suppl 2025
6439
Articles

Articles in this Issue

Barriers and facilitators of adoption and implementation of a financial navigation program in Nigeria: An analysis of participant data from the COST-FIN trial.

Adewale Isaiah Oyewole, Elizabeth N. Christian, Funmilola Olanike Wuraola et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.tps11187

TPS11187 Background: Financial toxicity is a critical issue in modern healthcare. The impact of financial toxicity is particularly pronounced in low- and...

Clinical and immunopathological evaluation and its comparison with consensus molecular subtypes of colorectal cancer.

Eduardo Feliciangeli, Ginés Luengo-Gil, Teresa García et al. Jun 01, 2025 pp. 3594-3594 10.1200/jco.2025.43.16_suppl.3594

3594 Background: This study aims to elucidate the prognostic impact of the immunoscore within the context of consensus molecular subtypes (CMS), tumor bud...

Real-world data vs pivotal trial outcomes of imatinib in newly diagnosed chronic myeloid leukemia patients.

Yazmin Reategui-Almonacid, Marisol Miranda, Joshua Wilson et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e18565

e18565 Background: Chronic myeloid leukemia (CML) is driven by the BCR::ABL1 fusion gene, resulting in uncontrolled tyrosine kinase activity. The introduc...

Institutional experience with pancreatic head versus body/tail cancer: A comparison of treatment outcomes.

Ebtesam Al-Najjar, Abdullah Esmail, Bayan Khasawneh et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e16436

e16436 Background: Pancreatic ductal adenocarcinoma (PDAC) continues to rise globally, with a poor prognosis and devastating outcomes. This study aims to...

Exploring the role of posthumous organ donation attitudes: A comparative study of Egyptian cancer patients and healthy individuals.

Ammal M. Metwally, Abdelrahman Hassanein, Safaa I. Abd El Hady et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e22605

e22605 Background: Organ transplantation is a critical intervention for patients with end-stage organ failure, including those suffering from cancer-relat...

Plasma proteome molecular sequencing–based prognostic nomogram in metastatic castrate-resistant prostate cancer (mCRPC).

Manish Kohli, Joseph Finklestein, Claire Hanson et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e17057

e17057 Background: Currently non-specific protein factors (Alkaline Phosphatase-ALK, LDH, albumin) are used for identifying prognostic risk groups in mCRP...

Obesity-related cancer mortality in the US (1999–2020): A CDC WONDER analysis.

Kainat Aman, Abdullah Zia, Aman Ullah et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e23052

e23052 Background: Obesity is a major public health issue and a key risk factor for various cancers. This study examines U.S. mortality trends (1999–2020)...

Immune checkpoint inhibition in EBV-associated gastric cancer: A multi-center international retrospective analysis.

Darren Cowzer, Choong-kun Lee, Joanne F. Chou et al. Jun 01, 2025 pp. 4043-4043 10.1200/jco.2025.43.16_suppl.4043

4043 Background: Epstein-Barr virus associated gastric cancer (EBVaGC) is found in ~9% of GC and is associated with a uniq...

Obesity paradox in non-small cell lung cancer (NSCLC) patients on immune checkpoint inhibitors: Real-world evidence using the global collaborative network database.

Oboseh John Ogedegbe, Olanipekun Lanny Ntukidem, Henry Becerra et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e20624

e20624 Background: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. Immune checkpoint inh...

Advancing pain and symptom management in cancer: A data-driven analysis of care delivery, psychosocial support, and communication strategies.

FNU Anamika, Akshit Chitkara, Sakshi Bai et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e13588

e13588 Background: Effective pain and symptom management is critical in cancer care, yet gaps exist in addressing psychosocial needs and communication str...

Conducting stoma-free intersphincteric resection for ultra-low rectal cancers by selective delayed coloanal anastomosis, a single center experience.

Wenchao Cao, Mingtian Wei, Yu Shen et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e15622

e15622 Background: Intersphincteric resection (ISR) is aimed at preserving the anus in patients with ultra-low rectal cancers (uLRCs). Previous reports sh...

Efficacy and safety of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: A prospective, single-arm, phase II trial.

Shengjie Sun, Xiao Zhao, Jing Zhang et al. Jun 01, 2025 pp. 8090-8090 10.1200/jco.2025.43.16_suppl.8090

8090 Background: Extensive-stage small cell lung cancer (ES-SCLC) is related to high malignancy and the poor prognosis. At present, immunotherapy combined...

Phase 2 cohort-2 trial in progress: Vabametkib plus lazertinib for patients with EGFR-mutant NSCLC who developed resistance to 1st-line, 3rd-gen-EGFR TKIs via C-Met dysregulation.

Dae Ho Lee, Hye Ryun Kim, Hanlim Moon et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.tps8662

TPS8662 Background: Third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) have emerged as a promising first-line treatm...

Association between perceived interpersonal support and quality of life among adult patients with cancer undergoing chemotherapy at an academic cancer institute.

Ian Lau, Hamid Torabzadeh, Wesley Peng et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e23181

e23181 Background: The National Cancer Institute (NCI) defines quality of life (QOL) as “overall enjoyment of life.” Increasingly, cancer care is focused...

Molecular testing in primary advanced or recurrent endometrial cancer: A cost-effectiveness analysis.

Yilin Chen, Solomon James Lubinga, Scott David Ramsey et al. Jun 01, 2025 pp. 5598-5598 10.1200/jco.2025.43.16_suppl.5598

5598 Background: The Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) algorithm is a classification scheme for endometrial cancer (EC)...

Pre-existing cancer as a risk factor for poor outcomes after burn injury.

Lyndon Huang, Phillip Keys, Juquan Song et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e24033

e24033 Background: With a growing population of cancer survivors, assessing health outcomes and improving patient care is increasingly important. Severe b...

Longitudinal ctDNA monitoring and prediction of anti-EGFR rechallenge outcomes in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): The REMARRY & PURSUIT trials.

Yoshinori Kagawa, Hiroya Taniguchi, Daisuke Kotani et al. Jun 01, 2025 pp. 3514-3514 10.1200/jco.2025.43.16_suppl.3514

3514 Background: Anti‐EGFR monoclonal antibody (mAb) rechallenge involves re‐administering EGFR blockade after a treatment‐free interval to exploit clonal...

Effect of chatbot utilization on genetic testing uptake in diverse clinic settings.

Madi Glorioso, Sienna Aguilar, Sarah Nielsen Young et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e13710

e13710 Background: Chatbots are a digital health tool used to identify patients who may benefit from genetic testing, provide pre-test educational content...

Virtual reality for pain and anxiety management during bone marrow biopsy: A systematic review.

Ronak Patel, Imad Karam, Alaukika Agarwal et al. Jun 01, 2025 pp. 12075-12075 10.1200/jco.2025.43.16_suppl.12075

12075 Background: Bone marrow biopsy (BMB) procedures often cause significant pain and anxiety. Virtual reality (VR) has emerged as a promising non-pharma...

From data to dollars: Evaluating the predictive power of enhancing oncology model risk adjusters.

Puneeth Indurlal, Jason Altieri, Alti Rahman et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e13894

e13894 Background: The Enhancing Oncology Model (EOM) is an oncology-specific, total cost of care, value-based payment model. Performance in the model is...

Evaluation of prediabetes as a potential risk factor for breast cancer: A systematic review and meta-analysis.

Rana H. Shembesh, Mohammed S. Beshr, Mohamed E. Ali et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e13168

e13168 Background: Recent research has shown conflicting results regarding the relationship between prediabetes and breast cancer. Factors such as insulin...

Prediction of extracapsular extension and seminal vesicle invasion in prostate cancer using preoperative MRI images combined with deep learning algorithms.

Zheng Liu, Weijie Gu, Fangning Wan et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e17139

e17139 Background: Extracapsular extension (ECE) and seminal vesicle invasion (SVI) are critical factors in determining nerve-sparing decisions during rad...

Feasibility of Pap-derived ctDNA for detection of sporadic and Lynch-associated endometrial cancer.

Alicia Latham, Jennifer Jean Mueller, Karmelina Charalambous et al. Jun 01, 2025 pp. 10503-10503 10.1200/jco.2025.43.16_suppl.10503

10503 Background: Patients (pts) with Lynch Syndrome (LS) have high risk of endometrial cancer (EC) and are recommended risk-reducing hysterectomy (RR-Hys...

Economic and clinical impact of influenza virus infection in hospitalized lung cancer patients: A National Inpatient Sample analysis.

Shakirat Gold-Olufadi, Kibwey Peterkin, Sravani Bhavanam et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e20086

e20086 Background: Lung cancer is a leading cause of cancer-related mortality, with patients often susceptible to complications from infections, including...

Evaluating the impact of long-term glucocorticoid use on cancer risk in patients with rheumatologic diseases: A retrospective cohort study.

Farigol Hakem Zadeh, Nikita Shah, Juan Varela et al. Jun 01, 2025 pp. 10532-10532 10.1200/jco.2025.43.16_suppl.10532

10532 Background: Long-term glucocorticoid (GC) therapy is widely used in the management of rheumatologic diseases, but its immunosuppressive effects have...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0732-183X
E-ISSN 1527-7755
Subject Health Sciences
Language English
View Full Journal Page